Cryotherapy for Prostate Cancer Treatment
WebMD explains cryotherapy, a treatment for recurring prostate cancer that involves freezing and killing cancer cells.
Prostate Cancer Clinical Trials
WebMD explains where and how to participate in a clinical trial for a new prostate cancer treatment.
Advanced Prostate Cancer: Frequently Asked Questions
WebMD answers frequently asked questions about advanced prostate cancer, offering a comprehensive look at the newest treatments.
Coping With Prostate Cancer
WebMD helps you navigate the practical and emotional aspects of dealing with a prostate cancer diagnosis.
Alternative Treatments for Prostate Cancer
WebMD examines alternative remedies for the prevention and treatment of prostate cancer, including the bark of the African plum tree, lycopene, pomegranate juice, and saw palmetto berry.
Prostate Cancer Screening (PDQ®): Screening - Patient Information [NCI] - Risks of Prostate Cancer Screening
Screening tests have risks.Decisions about screening tests can be difficult. Not all screening tests are helpful and most have risks. Before having any screening test, you may want to discuss the test with your doctor. It is important to know the risks of the test and whether it has been proven to reduce the risk of dying from cancer.The risks of prostate screening include the following:Finding prostate cancer may not improve health or help a man live longer.Screening may not improve your health or help you live longer if you have cancer that has already spread to the area outside of the prostate or to other places in your body. Some cancers never cause symptoms or become life-threatening, but if found by a screening test, the cancer may be treated. Finding these cancers is called overdiagnosis. It is not known if treatment of these cancers would help you live longer than if no treatment were given, and treatments for cancer, such as surgery and radiation therapy, may have serious
Prostate Cancer Screening (PDQ®): Screening - Health Professional Information [NCI] - Changes to This Summary (02 / 27 / 2014)
The PDQ cancer information summaries are reviewed regularly and updated as new information becomes available. This section describes the latest changes made to this summary as of the date above.Editorial changes were made to this summary.This summary is written and maintained by the PDQ Screening and Prevention Editorial Board, which is editorially independent of NCI. The summary reflects an independent review of the literature and does not represent a policy statement of NCI or NIH. More information about summary policies and the role of the PDQ Editorial Boards in maintaining the PDQ summaries can be found on the About This PDQ Summary and PDQ NCI's Comprehensive Cancer Database pages.
Prostate Cancer, Nutrition, and Dietary Supplements (PDQ®): Complementary and alternative medicine - Health Professional Information [NCI] - Lycopene
OverviewThis section contains the following key information:Lycopene is a carotenoid, a natural pigment made by plants and various fruits and vegetables, including tomatoes, apricot, guava, and watermelon.Lycopene's absorption is improved with concurrent dietary fat intake.Lycopene inhibits androgen receptor expression in prostate cancer cells in vitro and, along with some of its metabolites, reduces prostate cancer cell proliferation and may modulate cell-cycle progression.Lycopene may also affect the insulin-like growth factor intracellular pathway in prostate cancer cells.Results from several in vitro and animal studies have indicated that lycopene may have chemopreventive effects for cancers of the prostate, skin, breast, lung, and liver; however, human trials have been inconsistent in their findings. Clinical trials utilizing lycopene in prostate cancer patients with various different clinical presentations (e.g., early stage, prostate-specific
Prostate Cancer, Nutrition, and Dietary Supplements (PDQ®): Complementary and alternative medicine - Patient Information [NCI] - Changes to This Summary (10 / 16 / 2014)
When considering complementary and alternative therapies, patients should ask their health care provider the following questions: What side effects can be expected?What are the risks associated with this therapy?Do the known benefits outweigh the risks?What benefits can be expected from this therapy?Will the therapy interfere with conventional treatment?Is this therapy part of a clinical trial?If so, who is sponsoring the trial?Will the therapy be covered by health insurance?
Prostate Cancer Treatment (PDQ®): Treatment - Patient Information [NCI] - Treatment Options by Stage
A link to a list of current clinical trials is included for each treatment section. For some types or stages of cancer, there may not be any trials listed. Check with your doctor for clinical trials that are not listed here but may be right for you.Stage I Prostate CancerStandard treatment of stage I prostate cancer may include the following:Watchful waiting.Active surveillance. If the cancer begins to grow, hormone therapy may be given.Radical prostatectomy, usually with pelvic lymphadenectomy. Radiation therapy may be given after surgery.External-beam radiation therapy. Hormone therapy may be given after radiation therapy.Internal radiation therapy with radioactive seeds.A clinical trial of high-intensity focused ultrasound.A clinical trial of cryosurgery.Check for U.S. clinical trials from NCI's list of cancer clinical trials that are now accepting patients with stage I prostate cancer. For more specific results, refine the search by using other search features, such as the